| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jul 2, 2014
DUBLIN, Ireland--(BUSINESS WIRE)--FORM 8.1(a)&(b)(i) IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.1(a) AND (b)(i) OF THE IRISH TAKEOVER PANEL ACT, 1997, TA KEOVER RULES, 2013 DEALINGS BY OFFERORS,...
-
Jul 2, 2014Comparative Efficacy Results from the OpT2mise Trial Published in The Lancet Could Redefine Management of Insulin-Requiring Type 2 Diabetes
MINNEAPOLIS - July 2, 2014 - As an example of its commitment to improving clinical outcomes for all people with diabetes, Medtronic, Inc. (NYSE:MDT) today announced the results of the OpT2mise...
-
Jun 30, 2014
DUBLIN, Ireland--(BUSINESS WIRE)--Jun. 30, 2014-- In accordance with Rule 2.10 of the Irish Takeover Rules, Covidien plc (NYSE:COV) (the “Company”) confirms that, as of the close of business...
-
Jun 26, 2014
DUBLIN, Ireland--(BUSINESS WIRE)--Jun. 26, 2014-- Covidien plc (NYSE: COV) will report third-quarter fiscal 2014 results on July 25. The company will host a conference call for investors at 8:30...
-
Jun 25, 2014
MINNEAPOLIS - June 25, 2014 - Medtronic, Inc. (NYSE: MDT), today announced results from the CRYSTAL AF (CRYptogenic STroke And underLying Atrial Fibrillation) Clinical Trial have been published in...
-
Jun 24, 2014
DUBLIN, Ireland--(BUSINESS WIRE)--Jun. 24, 2014-- Covidien (NYSE: COV) today announced that it filed a lawsuit in the U.S. District Court for the District of Connecticut against Ethicon...
-
Jun 24, 2014
DUBLIN--(BUSINESS WIRE)--Jun. 24, 2014-- In accordance with Rule 2.10 of the Irish Takeover Rules, Covidien plc (NYSE: COV) (the “Company”) confirms that, as of the close of business on June...
-
Jun 24, 2014Minimally-invasive flow diversion device for unruptured brain aneurysms designed for more accurate, controlled placement1
DUBLIN, Ireland--(BUSINESS WIRE)--Jun. 24, 2014-- Further strengthening its broad line of neurovascular products to treat unruptured brain aneurysms, Covidien plc (NYSE:COV) announced the European...
-
Jun 20, 2014
DUBLIN--(BUSINESS WIRE)--Jun. 20, 2014-- In accordance with Rule 2.10 of the Irish Takeover Rules, Covidien plc (NYSE: COV) (the “Company”) confirms that, as of the close of business on June...
-
Jun 20, 2014
DUBLIN--(BUSINESS WIRE)--Jun. 20, 2014-- In accordance with Rule 2.10 of the Irish Takeover Rules, Covidien plc (NYSE: COV) (the “Company”) confirms that, as of the close of business on June...